Cardiff Oncology, Inc. - Common Stock (CRDF)

Historical Holders from Q2 2020 to Q3 2025

Symbol
CRDF on Nasdaq
CUSIP
14147L108
Type / Class
Equity / Common Stock
Shares outstanding
66.6M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
25.2M
Holdings value
$51.8M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
109
Number of buys
48
Number of sells
-49
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cardiff Oncology, Inc. - Common Stock (CRDF)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 5.8% +37.5% $9.14M $2.38M 3.84M +35.2% BlackRock, Inc. Mar 31, 2025
VANGUARD GROUP INC 5.6% $10.1M 3.73M The Vanguard Group Jun 30, 2025
PFIZER INC 3.6% $5.74M 2.41M Pfizer Inc. 13-5315170 Dec 31, 2024

Institutional Holders of Cardiff Oncology, Inc. - Common Stock (CRDF)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 25.2M $51.8M -$9.7M $2.06 109
2025 Q2 28.7M $90.3M -$11.3M $3.15 114
2025 Q1 32.3M $102M +$10.2M $3.14 116
2024 Q4 28.1M $122M +$50.2M $4.34 117
2024 Q3 12.8M $34.1M -$900K $2.67 83
2024 Q2 12.8M $28.4M +$5.43M $2.22 89
2024 Q1 8.58M $45.8M +$17.6M $5.34 75
2023 Q4 5.28M $7.81M -$209K $1.48 53
2023 Q3 5.42M $7.54M -$761K $1.39 55
2023 Q2 5.96M $8.76M -$1.4M $1.47 48
2023 Q1 7.03M $11.6M -$750K $1.65 50
2022 Q4 7.68M $10.8M -$321K $1.40 53
2022 Q3 7.92M $12.2M -$1.96M $1.54 48
2022 Q2 7.86M $17.3M -$14.1M $2.20 49
2022 Q1 13.8M $34.2M -$29.2M $2.48 78
2021 Q4 21.4M $128M +$2.41M $6.01 78
2021 Q3 21M $140M -$33.6M $6.66 84
2021 Q2 26.4M $175M +$10.1M $6.65 83
2021 Q1 24.1M $223M -$73.1M $9.26 69
2020 Q4 25.7M $462M +$144M $17.99 74
2020 Q3 18.7M $265M +$208M $14.19 61
2020 Q2 4.92M $24.7M +$24.7M $5.01 22